Strengthening the Medtech Business Through AI, IoT and Mechatronics
First written in FY2023. 6 of 7 entries say "Advanced", first in FY2024. Latest entry: 2026-08-06.
6 other companies' latest entry also says "Advanced".
- 2026-08-06AdvancedRevision of earnings forecasts
「In the medical systems business, we promoted market penetration of distinctive new products combining AI and IoT technologies with image analysis, while implementing measures to improve profitability, including improving gross profit by emphasizing value and scaling back low-profitability products.」
The medtech initiatives expanded from market penetration of products combining AI and IoT technologies to improving profitability through value-based selling and scaling back low-profitability products. - FY2026AdvancedAnnual report
「Under “Strengthening the MedTech business,” efforts were made to roll out mass spectrometry systems for processing multiple specimens for the clinical market and to expand the lineup of dedicated instruments and reagents.」
The medtech business has taken concrete shape, expanding from transforming medical imaging through AI image analysis and IoT to market development of high-throughput multi-sample processing MS systems, dedicated instruments, reagents and X-ray imaging systems for the clinical market. - FY2026-H1AdvancedAnnual report
「In the medical equipment business, the Group rolled out measures to penetrate the market with new products combining image analysis with AI and IoT technologies, with the aim of extending healthy life expectancy and improving the operational efficiency of healthcare professionals.」
The use of AI and IoT in the medtech business has taken concrete form in market penetration initiatives for new products aimed at extending healthy life expectancy and improving the operational efficiency of healthcare professionals. - FY2025AdvancedAnnual report
「We also promoted “imaging transformation” using AI and IoT technologies for medical image analysis, and launched an X-ray imaging system equipped with an optical camera in April 2024.」
The use of AI, IoT, and mechatronics in the MedTech business progressed into the commercialization of products including an X-ray imaging system equipped with an optical camera, voice recognition functions, and examination support software. - FY2025-H1AdvancedAnnual report
「With the aim of strengthening the medtech business, the company expanded fully automated sample preparation systems, reagents, software, and other products for the clinical market and proceeded to build its business foundation.」
In the MedTech business, the company is expanding fully automated sample preparation systems, reagents and software for the clinical market, and has moved toward concretely building the foundations for the business. - FY2024AdvancedAnnual report
「In the medtech field, the company is advancing the provision of solutions that combine component analysis and image analysis technologies to support healthy longevity, while also conducting research and development related to infectious diseases and Alzheimer’s disease in collaboration with partners.」
The medtech business has been developed from a policy of using AI, IoT and mechatronics into specific initiatives combining component analysis with image analysis and joint research and development in infectious diseases and Alzheimer's disease. - FY2023First statedAnnual report
「In the medtech business, we aim to contribute further to healthcare through the transformation of X-ray image analysis using AI and IoT and through mechatronics technologies. We will strengthen mass spectrometry systems, culture-medium-related technologies, and microbial testing technologies and provide a broad range of products and services to the clinical testing field.」
The medtech business was positioned as a new business strategy covering health management, testing, diagnosis, treatment, and prognosis management, combining AI, IoT, mechatronics, mass spectrometry, culture-medium, and microbial-testing technologies.